NewsBur
No Result
View All Result
Saturday, January 16, 2021
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
Subscribe
Newsbur
  • Home
  • Morning News
  • Market News
  • Analyst Actions
  • Trending Stocks
No Result
View All Result
Newsbur
No Result
View All Result
Home Trending Stocks

Syneos Health Inc. (SYNH) down by -0.98% After Wednesday’s trading session. Will the Healthcare stock keep up the recovery effort?

by Timothy Webb
July 2, 2020
in Trending Stocks
0
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

Syneos Health Inc. (NASDAQ:SYNH) went down by -0.98% during the previous trading session, and it is maintaining the win ahead of Wednesday’s trading session. The share price of the Diagnostics & Research giant went up by $57.68 to trade ended Wednesday trading at $58.25. This is down from the $58.25 price recorded on Tuesday’s trading session. Thanks to this latest performance, SYNH is closer to the higher price 52-week target of $77.00 and further from the lowest price target of $50.00. Its performance from the start of the year has also been negative, with SYNH down by -3.02% year-to-date.

Syneos Health Inc. (SYNH) started the day trading at $58.52 and recorded an intraday high of $58.85. It also recorded an intraday low of $57.13 during Wednesday’s trading session. Syneos Health Inc. is a very active stock that recorded a trading volume that is less than -41.7% of the average daily trading volume on Wednesday. The stock’s trading volume on Wednesday was 532754, which is less than -41.7 of the total average daily trading volume of 754.92K.

Syneos Health Inc. (NASDAQ:SYNH) 2020 Performance Impressive

The increase in SYNH’s stock price on Wednesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of SYNH currently stands at $74.25, which is higher than the current trading price of the stock by 22.32%. However, SYNH’s current trading price is -92.14% lower than the 52-week low price of $30.02. In terms of trading volume, Syneos Health Inc. currently experienced healthy participation during the last trading session. 532754 shares of Syneos Health Inc. were traded on the stock exchange on Wednesday, which is less than -41.7% of the 754.92K average trading volume of the stock.

The performance of the stock has been positive over the past year. SYNH’s performance over the past one year has seen it surge by 13.61%, while the stock has gone down by -3.02% in the last six months. The quarterly performance of SYNH currently stands at 59.43%, and it is down by -5.80% in the last month. The only positive figure was from the weekly performance, which currently reads 6.30%. At the time of writing SYNH’s report, the company has a total market cap of $5.96B, making it one of the largest publicly-traded companies in the world.Syneos Health Inc. also has over 24000 employees all over the world.

SYNH Insider Activities

The insider transactions over the past six months are up by 71.40%.For Syneos Health Inc. insiders bought 197,008 shares in 29 transactions. In that same period, insiders sold 55,326 of their shares in 16 transactions. After these transactions, insiders at Syneos Health Inc. now hold 444.8k shares, which is over 107.31% of the total company stocks. Institutional investors currently hold a large chunk of the SYNH shares, as they control 0.43% of the company’s total stock.

SYNH Fundamental Analysis

For Syneos Health Inc., the stock’s diluted earnings per share (EPS) stands at 1.85. In the coming year, analysts expect the EPS to be 3.71. The stock’s EPS growth this year is 467.60%, with analysts expecting almost a 1 growth in the earnings per share next week. In terms of revenue, Syneos Health Inc.’s quarterly sales (YOY) is growing at 0.47, which is lower than the average annual revenue of 34.80% over the past half a decade.

The Return on Investment (ROI) on Syneos Health Inc.’s stock currently stands at 4.90%, and it has a net profit margin of 4.10%. The operating margin of the company is 5.80%, and its gross margin is 22.00%.

SYNH Analysts Prediction

In March 30, 2020, several analysts reiterated their positions on the Syneos Health Inc. stock and predicted its performance to their investors. The analysts at Goldman believe SYNH is still a Neutral and set the price target between $79 and $45.

At the moment, Syneos Health Inc.’s Total Debt to Equity ratio stands at 0.99, and they have a long-term Debt to Equity ratio of 0.96.

SYNH Technical Analysis

The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of SYNH currently stands at 2.46%, while the SMA50 is 2.73%. The biggest one is the SMA200, which is currently reading 4.39% ahead of Wednesday’s trading session. The Relative Strength Index of this stock is 54.98, while its price to earnings ratio (P/E) is 31.16.

Tags: NASDAQ:SYNHSyneos Health Inc.SYNHSYNH stock

Recommended Stories

Rockwell Medical Inc. [RMTI] Is Skyrocketing 1.43% on Pure Fundamentals

September 30, 2020

Heat Biologics Inc. [HTBX] Can’t Seem to Gain Investor Confidence as Volume Dips to 14080670

September 9, 2020

eBay Inc. [EBAY] is One of the Best Plays in Consumer Cyclical and This Proves It

September 30, 2020

Popular Stories

  • Sorrento Therapeutics Inc. [SRNE] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] is One of the Best Plays in Healthcare and This Proves It

    0 shares
    Share 0 Tweet 0
  • Heat Biologics Inc. [HTBX] Is Skyrocketing 13.15% on Pure Fundamentals

    0 shares
    Share 0 Tweet 0
  • BlackBerry Limited [BB] is a Top Ten Buy with Quarterly Revenues of 999.00M

    0 shares
    Share 0 Tweet 0
  • Impressive Profit Margins of -5.80% Raise Bull Flags for General Electric Company [GE]

    0 shares
    Share 0 Tweet 0

NewsBur.com

Newsbur.com is an Economic news website, which offers broad information about the Stock markets and Equities. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis.

Recent Posts

  • After-Hours Trading Alert: Amgen Inc. [AMGN] is Up 0.85% After the Bell
  • Has Dynatrace Inc. [DT] Completely Outpaced Other Companies in the Technology This Year?
  • Why Applied Materials Inc. [AMAT]’s 1.55% Drop is No Cause for Alarm

Categories

  • Analyst Actions
  • Market News
  • Morning News
  • Trending Stocks
  • Uncategorized

© 2020 Copyright © All Rights Reserved.

No Result
View All Result
  • Home
  • Market News
  • Morning News
  • Analyst Actions
  • Trending Stocks

© 2020 Copyright © All Rights Reserved.